AngelMed receives USA FDA approval

28 June 2021

Australian Stock Exchange (ASX) announcement on AngleMed USA FDA approval for the AngelMed Guardian®

First in human trials of PHYRARI FFR-WIRE

10 December 2020

First-in-human (FIH) trial of PHYRARI FFR-WIRE to be undertaken at Melbourne-based training hospital

Distribution Announcement

30 October 2020

Hydrix announces exclusive agreement to distribute novel cardiovascular technology – the PHYRARI FFR-WIRE

Female Patient receives AngelMed Guardian

22 October 2020

The first female patient in Singapore has received an AngelMed Guardian implant

AngelMed Implants in Singapore

27 August 20202

Singaporean patients post-operative implant procedures have been completed

First AngelMed Guardian Implants in Asia-Pacific

17 August 2020

Australian Stock Exchange (ASX) announcement on AngelMed Guardian implants in Singapore


13 March 2020

Hydrix completes acquisition of AngelMed Guardian®

Hydrix Services

Product design, engineering and regulatory consulting services to medical device companies

Connect with Hydrix Medical
for all enquiries